Jun 11 |
Regeneron Pharmaceuticals, Inc. (REGN) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
|
Jun 11 |
Regeneron, Sanofi win FDA label expansion for arthritis therapy Kevzara
|
Jun 11 |
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)
|
Jun 8 |
Is Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock's Recent Performance A Reflection Of Its Financial Health?
|
Jun 7 |
Stock Split Watch: 3 Growth Stocks That Could Be Next
|
Jun 5 |
Regeneron Pharmaceuticals, Inc. (REGN) Management presents at Jefferies 2024 Global Healthcare Conference (Transcript)
|
Jun 4 |
Health Care Stocks Show Relative Strength as S&P 500 Stalls
|
Jun 3 |
FibroGen Stock Is Surging After The Bell: What's Going On?
|
Jun 3 |
Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) the Best Bet in Gene Therapy Industry?
|
May 31 |
FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
|